Now that you have completed this activity, please provide feedback regarding its quality and the impact it will have on your practice. Learning Objectives Please rate your ability to perform the following objectives upon completion of this activity, with 1 = Not confident and 5 = Able to demonstrate * 12345 12345 Learning Objective 1: Discuss a strategy for laboratory testing in patients with recurrent infection utilizing flow cytometry and functional immune testing to clarify the diagnosis and therapeutic options Learning Objective 1: Discuss a strategy for laboratory testing in patients with recurrent infection utilizing flow cytometry and functional immune testing to clarify the diagnosis and therapeutic options - 1 Learning Objective 1: Discuss a strategy for laboratory testing in patients with recurrent infection utilizing flow cytometry and functional immune testing to clarify the diagnosis and therapeutic options - 2 Learning Objective 1: Discuss a strategy for laboratory testing in patients with recurrent infection utilizing flow cytometry and functional immune testing to clarify the diagnosis and therapeutic options - 3 Learning Objective 1: Discuss a strategy for laboratory testing in patients with recurrent infection utilizing flow cytometry and functional immune testing to clarify the diagnosis and therapeutic options - 4 Learning Objective 1: Discuss a strategy for laboratory testing in patients with recurrent infection utilizing flow cytometry and functional immune testing to clarify the diagnosis and therapeutic options - 5 Learning Objective 2: Discuss the principles of specific IgE testing and the utility of tryptase testing Learning Objective 2: Discuss the principles of specific IgE testing and the utility of tryptase testing - 1 Learning Objective 2: Discuss the principles of specific IgE testing and the utility of tryptase testing - 2 Learning Objective 2: Discuss the principles of specific IgE testing and the utility of tryptase testing - 3 Learning Objective 2: Discuss the principles of specific IgE testing and the utility of tryptase testing - 4 Learning Objective 2: Discuss the principles of specific IgE testing and the utility of tryptase testing - 5 Learning Objective 3: Identify the rationale and approach including HLA typing, donor selection and use of conditioning for hematopoietic stem cell transplantation for patients with primary immune deficiencies and how these approaches differ for SCID, Wiskott Aldrich Syndrome and Chronic Granulomatous Disease Learning Objective 3: Identify the rationale and approach including HLA typing, donor selection and use of conditioning for hematopoietic stem cell transplantation for patients with primary immune deficiencies and how these approaches differ for SCID, Wiskott Aldrich Syndrome and Chronic Granulomatous Disease - 1 Learning Objective 3: Identify the rationale and approach including HLA typing, donor selection and use of conditioning for hematopoietic stem cell transplantation for patients with primary immune deficiencies and how these approaches differ for SCID, Wiskott Aldrich Syndrome and Chronic Granulomatous Disease - 2 Learning Objective 3: Identify the rationale and approach including HLA typing, donor selection and use of conditioning for hematopoietic stem cell transplantation for patients with primary immune deficiencies and how these approaches differ for SCID, Wiskott Aldrich Syndrome and Chronic Granulomatous Disease - 3 Learning Objective 3: Identify the rationale and approach including HLA typing, donor selection and use of conditioning for hematopoietic stem cell transplantation for patients with primary immune deficiencies and how these approaches differ for SCID, Wiskott Aldrich Syndrome and Chronic Granulomatous Disease - 4 Learning Objective 3: Identify the rationale and approach including HLA typing, donor selection and use of conditioning for hematopoietic stem cell transplantation for patients with primary immune deficiencies and how these approaches differ for SCID, Wiskott Aldrich Syndrome and Chronic Granulomatous Disease - 5 Learning Objective 4: Discuss the approaches and risks using exogenous gene therapy for patients with primary immune deficiencies including SCID, Wiskott Aldrich Syndrome and Chronic Granulomatous Disease Learning Objective 4: Discuss the approaches and risks using exogenous gene therapy for patients with primary immune deficiencies including SCID, Wiskott Aldrich Syndrome and Chronic Granulomatous Disease - 1 Learning Objective 4: Discuss the approaches and risks using exogenous gene therapy for patients with primary immune deficiencies including SCID, Wiskott Aldrich Syndrome and Chronic Granulomatous Disease - 2 Learning Objective 4: Discuss the approaches and risks using exogenous gene therapy for patients with primary immune deficiencies including SCID, Wiskott Aldrich Syndrome and Chronic Granulomatous Disease - 3 Learning Objective 4: Discuss the approaches and risks using exogenous gene therapy for patients with primary immune deficiencies including SCID, Wiskott Aldrich Syndrome and Chronic Granulomatous Disease - 4 Learning Objective 4: Discuss the approaches and risks using exogenous gene therapy for patients with primary immune deficiencies including SCID, Wiskott Aldrich Syndrome and Chronic Granulomatous Disease - 5 Learning Objective 5: Describe the biologics that may be useful in patients with atopic asthma Learning Objective 5: Describe the biologics that may be useful in patients with atopic asthma - 1 Learning Objective 5: Describe the biologics that may be useful in patients with atopic asthma - 2 Learning Objective 5: Describe the biologics that may be useful in patients with atopic asthma - 3 Learning Objective 5: Describe the biologics that may be useful in patients with atopic asthma - 4 Learning Objective 5: Describe the biologics that may be useful in patients with atopic asthma - 5 Learning Objective 6: Describe replacement immunoglobulin therapy in patients with antibody deficiency and identify the possible risk factors that may lead to adverse events of the therapy Learning Objective 6: Describe replacement immunoglobulin therapy in patients with antibody deficiency and identify the possible risk factors that may lead to adverse events of the therapy - 1 Learning Objective 6: Describe replacement immunoglobulin therapy in patients with antibody deficiency and identify the possible risk factors that may lead to adverse events of the therapy - 2 Learning Objective 6: Describe replacement immunoglobulin therapy in patients with antibody deficiency and identify the possible risk factors that may lead to adverse events of the therapy - 3 Learning Objective 6: Describe replacement immunoglobulin therapy in patients with antibody deficiency and identify the possible risk factors that may lead to adverse events of the therapy - 4 Learning Objective 6: Describe replacement immunoglobulin therapy in patients with antibody deficiency and identify the possible risk factors that may lead to adverse events of the therapy - 5 Thomas A. Fleisher, MD FAAAAI Laboratory Immunology - Thomas A. Fleisher, MD FAAAAI * Strongly DisagreeDisagreeNeutralAgreeStrongly Agree Strongly DisagreeDisagreeNeutralAgreeStrongly Agree Disclosed potential conflicts of interest before beginning the activity Disclosed potential conflicts of interest before beginning the activity - Strongly Disagree Disclosed potential conflicts of interest before beginning the activity - Disagree Disclosed potential conflicts of interest before beginning the activity - Neutral Disclosed potential conflicts of interest before beginning the activity - Agree Disclosed potential conflicts of interest before beginning the activity - Strongly Agree Demonstrated appropriate expertise in the subject area Demonstrated appropriate expertise in the subject area - Strongly Disagree Demonstrated appropriate expertise in the subject area - Disagree Demonstrated appropriate expertise in the subject area - Neutral Demonstrated appropriate expertise in the subject area - Agree Demonstrated appropriate expertise in the subject area - Strongly Agree Demonstrated effective presentation skills that engaged the audience Demonstrated effective presentation skills that engaged the audience - Strongly Disagree Demonstrated effective presentation skills that engaged the audience - Disagree Demonstrated effective presentation skills that engaged the audience - Neutral Demonstrated effective presentation skills that engaged the audience - Agree Demonstrated effective presentation skills that engaged the audience - Strongly Agree Provided syllabus materials that enhanced learning from the presentation Provided syllabus materials that enhanced learning from the presentation - Strongly Disagree Provided syllabus materials that enhanced learning from the presentation - Disagree Provided syllabus materials that enhanced learning from the presentation - Neutral Provided syllabus materials that enhanced learning from the presentation - Agree Provided syllabus materials that enhanced learning from the presentation - Strongly Agree Should be invited to present at future courses Should be invited to present at future courses - Strongly Disagree Should be invited to present at future courses - Disagree Should be invited to present at future courses - Neutral Should be invited to present at future courses - Agree Should be invited to present at future courses - Strongly Agree Provided a presentation that prepared you for your upcoming certification/recertification Provided a presentation that prepared you for your upcoming certification/recertification - Strongly Disagree Provided a presentation that prepared you for your upcoming certification/recertification - Disagree Provided a presentation that prepared you for your upcoming certification/recertification - Neutral Provided a presentation that prepared you for your upcoming certification/recertification - Agree Provided a presentation that prepared you for your upcoming certification/recertification - Strongly Agree Morton Cowan, MD HLA, Stem Cell Transplantation and Gene Therapy - Morton Cowan, MD * Strongly DisagreeDisagreeNeutralAgreeStrongly Agree Strongly DisagreeDisagreeNeutralAgreeStrongly Agree Disclosed potential conflicts of interest before beginning the activity Disclosed potential conflicts of interest before beginning the activity - Strongly Disagree Disclosed potential conflicts of interest before beginning the activity - Disagree Disclosed potential conflicts of interest before beginning the activity - Neutral Disclosed potential conflicts of interest before beginning the activity - Agree Disclosed potential conflicts of interest before beginning the activity - Strongly Agree Demonstrated appropriate expertise in the subject area Demonstrated appropriate expertise in the subject area - Strongly Disagree Demonstrated appropriate expertise in the subject area - Disagree Demonstrated appropriate expertise in the subject area - Neutral Demonstrated appropriate expertise in the subject area - Agree Demonstrated appropriate expertise in the subject area - Strongly Agree Demonstrated effective presentation skills that engaged the audience Demonstrated effective presentation skills that engaged the audience - Strongly Disagree Demonstrated effective presentation skills that engaged the audience - Disagree Demonstrated effective presentation skills that engaged the audience - Neutral Demonstrated effective presentation skills that engaged the audience - Agree Demonstrated effective presentation skills that engaged the audience - Strongly Agree Provided syllabus materials that enhanced learning from the presentation Provided syllabus materials that enhanced learning from the presentation - Strongly Disagree Provided syllabus materials that enhanced learning from the presentation - Disagree Provided syllabus materials that enhanced learning from the presentation - Neutral Provided syllabus materials that enhanced learning from the presentation - Agree Provided syllabus materials that enhanced learning from the presentation - Strongly Agree Should be invited to present at future courses Should be invited to present at future courses - Strongly Disagree Should be invited to present at future courses - Disagree Should be invited to present at future courses - Neutral Should be invited to present at future courses - Agree Should be invited to present at future courses - Strongly Agree Provided a presentation that prepared you for your upcoming certification/recertification Provided a presentation that prepared you for your upcoming certification/recertification - Strongly Disagree Provided a presentation that prepared you for your upcoming certification/recertification - Disagree Provided a presentation that prepared you for your upcoming certification/recertification - Neutral Provided a presentation that prepared you for your upcoming certification/recertification - Agree Provided a presentation that prepared you for your upcoming certification/recertification - Strongly Agree Mark Ballow, MD FAAAAI IV/SC Ig and Biological Modifiers - Mark Ballow, MD FAAAAI * Strongly DisagreeDisagreeNeutralAgreeStrongly Agree Strongly DisagreeDisagreeNeutralAgreeStrongly Agree Disclosed potential conflicts of interest before beginning the activity Disclosed potential conflicts of interest before beginning the activity - Strongly Disagree Disclosed potential conflicts of interest before beginning the activity - Disagree Disclosed potential conflicts of interest before beginning the activity - Neutral Disclosed potential conflicts of interest before beginning the activity - Agree Disclosed potential conflicts of interest before beginning the activity - Strongly Agree Demonstrated appropriate expertise in the subject area Demonstrated appropriate expertise in the subject area - Strongly Disagree Demonstrated appropriate expertise in the subject area - Disagree Demonstrated appropriate expertise in the subject area - Neutral Demonstrated appropriate expertise in the subject area - Agree Demonstrated appropriate expertise in the subject area - Strongly Agree Demonstrated effective presentation skills that engaged the audience Demonstrated effective presentation skills that engaged the audience - Strongly Disagree Demonstrated effective presentation skills that engaged the audience - Disagree Demonstrated effective presentation skills that engaged the audience - Neutral Demonstrated effective presentation skills that engaged the audience - Agree Demonstrated effective presentation skills that engaged the audience - Strongly Agree Provided syllabus materials that enhanced learning from the presentation Provided syllabus materials that enhanced learning from the presentation - Strongly Disagree Provided syllabus materials that enhanced learning from the presentation - Disagree Provided syllabus materials that enhanced learning from the presentation - Neutral Provided syllabus materials that enhanced learning from the presentation - Agree Provided syllabus materials that enhanced learning from the presentation - Strongly Agree Should be invited to present at future courses Should be invited to present at future courses - Strongly Disagree Should be invited to present at future courses - Disagree Should be invited to present at future courses - Neutral Should be invited to present at future courses - Agree Should be invited to present at future courses - Strongly Agree Provided a presentation that prepared you for your upcoming certification/recertification Provided a presentation that prepared you for your upcoming certification/recertification - Strongly Disagree Provided a presentation that prepared you for your upcoming certification/recertification - Disagree Provided a presentation that prepared you for your upcoming certification/recertification - Neutral Provided a presentation that prepared you for your upcoming certification/recertification - Agree Provided a presentation that prepared you for your upcoming certification/recertification - Strongly Agree Commerical Bias Did you detect any commercial bias in this activity? * Yes No No Answer If you detected bias, please describe the biased content: Change in Practice Based on knowledge and skills you gained in completing this activity, do you plan to make changes to your practice (patient care, research, or teaching)? * Yes No No Answer If you plan to change your practice based on what you have learned, please describe below: If you have not made or do not plan to make changes to your practice based on what you learned by completing this activity, please indicate why. Select all that apply: Need to learn more before I feel comfortable changing my practice Knowledge and skills I gained did not have an immediate application Knowledge and skills I gained reinforced my current practice behaviors Financial limitations Staffing limitations Other: If you have not made or do not plan to make changes to your practice based on what you learned by completing this activity, please indicate why. Select all that apply: Other: Additional Comments After attending this activity, what do you need to learn more about to improve your practice (patient care, research, or teaching)? Please provide any additional comments you would like to share: Leave this field blank
